Zacks Research Issues Positive Estimate for Sanofi Earnings

Sanofi (NASDAQ:SNY - Free Report) - Equities researchers at Zacks Research increased their Q1 2026 EPS estimates for Sanofi in a research report issued on Thursday, June 12th. Zacks Research analyst K. Shah now forecasts that the company will earn $1.07 per share for the quarter, up from their previous forecast of $1.01. The consensus estimate for Sanofi's current full-year earnings is $4.36 per share. Zacks Research also issued estimates for Sanofi's Q2 2026 earnings at $1.13 EPS, Q3 2026 earnings at $1.31 EPS, Q4 2026 earnings at $1.21 EPS, FY2026 earnings at $4.71 EPS, Q1 2027 earnings at $1.15 EPS and FY2027 earnings at $5.14 EPS.

A number of other research firms have also issued reports on SNY. The Goldman Sachs Group initiated coverage on shares of Sanofi in a report on Friday, March 21st. They set a "neutral" rating and a $65.00 price target on the stock. Hsbc Global Res upgraded shares of Sanofi to a "strong-buy" rating in a report on Monday, April 28th. Morgan Stanley set a $56.00 price target on shares of Sanofi in a report on Monday, June 2nd. Guggenheim restated a "buy" rating on shares of Sanofi in a report on Tuesday, June 3rd. Finally, BNP Paribas began coverage on shares of Sanofi in a research note on Tuesday, April 15th. They issued an "outperform" rating and a $65.00 price objective on the stock. Three investment analysts have rated the stock with a hold rating, three have assigned a buy rating and three have assigned a strong buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Buy" and an average target price of $61.50.

Sanofi Stock Down 2.3%

SNY stock opened at $49.67 on Monday. Sanofi has a 52-week low of $45.80 and a 52-week high of $60.12. The company's 50 day simple moving average is $51.49 and its 200-day simple moving average is $52.06. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.46 and a quick ratio of 1.14. The firm has a market capitalization of $121.81 billion, a P/E ratio of 19.95, a P/E/G ratio of 1.01 and a beta of 0.50.

Sanofi (NASDAQ:SNY - Get Free Report) last released its quarterly earnings results on Thursday, April 24th. The company reported $0.94 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.90 by $0.04. Sanofi had a net margin of 12.77% and a return on equity of 25.61%. The business had revenue of $10.41 billion for the quarter, compared to analyst estimates of $9.79 billion. During the same quarter in the previous year, the business earned $1.78 earnings per share. The firm's revenue was down 11.0% compared to the same quarter last year.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the stock. Allspring Global Investments Holdings LLC increased its stake in Sanofi by 128.0% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 115,330 shares of the company's stock valued at $5,558,000 after buying an additional 64,747 shares during the period. Geode Capital Management LLC grew its position in Sanofi by 1.1% in the fourth quarter. Geode Capital Management LLC now owns 257,655 shares of the company's stock worth $12,427,000 after acquiring an additional 2,917 shares in the last quarter. Charles Schwab Investment Management Inc. grew its position in Sanofi by 8.9% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 151,945 shares of the company's stock worth $7,328,000 after acquiring an additional 12,440 shares in the last quarter. IFP Advisors Inc grew its position in Sanofi by 17.2% in the fourth quarter. IFP Advisors Inc now owns 2,132 shares of the company's stock worth $103,000 after acquiring an additional 313 shares in the last quarter. Finally, Jones Financial Companies Lllp grew its position in Sanofi by 55.0% in the fourth quarter. Jones Financial Companies Lllp now owns 15,122 shares of the company's stock worth $729,000 after acquiring an additional 5,366 shares in the last quarter. Institutional investors and hedge funds own 14.04% of the company's stock.

Sanofi Increases Dividend

The business also recently disclosed an annual dividend, which was paid on Thursday, June 12th. Shareholders of record on Friday, May 9th were paid a $2.0369 dividend. This represents a yield of 3.1%. The ex-dividend date of this dividend was Friday, May 9th. This is a positive change from Sanofi's previous annual dividend of $1.48. Sanofi's dividend payout ratio is currently 56.79%.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.